Abstract |
CD8+ T lymphocytes recognize tumor and viral antigens bound to class I major histocompatibility complexes (MHC). Tumors and viruses may evade detection by preventing antigen presentation. The present study was designed to determine whether a soluble divalent fusion protein, containing the extracellular domains of a class I MHC molecule fused to beta2-microglobulin and the constant domains of IgG1, could induce an immune response in vivo. Administration to mice of the fusion protein loaded with a tumor peptide induced peptide-specific T cell activation and retarded tumor growth. Administration of the fusion protein loaded with a glycoprotein B (gB) peptide derived from herpes simplex virus type 1 (HSV-1) induced gB-specific cytotoxic T lymphocytes and protected mice from a lethal HSV-1 challenge. These data suggest that antigen-loaded MHC/ IgG fusion proteins may enhance T cell immunity in conditions where antigen presentation is altered.
|
Authors | Brenna Carey, Monica DeLay, Jane E Strasser, Claudia Chalk, Kristen Dudley-McClain, Gregg N Milligan, Hermine I Brunner, Sherry Thornton, Raphael Hirsch |
Journal | Clinical immunology (Orlando, Fla.)
(Clin Immunol)
Vol. 116
Issue 1
Pg. 65-76
(Jul 2005)
ISSN: 1521-6616 [Print] United States |
PMID | 15925833
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Histocompatibility Antigens Class I
- Immunoglobulin G
- Peptide Fragments
- Recombinant Fusion Proteins
|
Topics |
- Animals
- CD8-Positive T-Lymphocytes
(immunology)
- Female
- Herpes Simplex
(immunology, mortality)
- Herpesvirus 1, Human
(immunology)
- Histocompatibility Antigens Class I
(genetics, immunology)
- Immunoglobulin G
(genetics, immunology)
- Lymphocyte Activation
(immunology, physiology)
- Mice
- Mice, Inbred C57BL
- Neoplasms
(drug therapy, immunology)
- Peptide Fragments
(immunology)
- Recombinant Fusion Proteins
(genetics, immunology, pharmacology)
- T-Lymphocyte Subsets
(immunology)
- T-Lymphocytes, Cytotoxic
(immunology)
|